title: Don't 'agonise' over the mechanisms underlying beta-agonist-induced muscle hypertrophy!
authors.affiliation: University of Nottingham, Division of Clinical Physiology, School of Graduate Entry Medicine and Health, Royal Derby Hospital, Uttoxeter Road, Derby DE22 3DT, UK. philip.atherton@nottingham.ac.uk
authors.forename: P J
authors.initials: PJ
authors.lastname: Atherton
authors.forename: N J
authors.initials: NJ
authors.lastname: Szewczyk
mesh_terms: D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D002154:Calpain / Q000378:metabolism; D004983:Ethanolamines / Q000494:pharmacology*; D000068759:Formoterol Fumarate; D006801:Humans; D006984:Hypertrophy; D051379:Mice; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D009133:Muscular Atrophy / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009929:Organ Size; D014176:Protein Biosynthesis / Q000187:drug effects; D015398:Signal Transduction / Q000187:drug effects; D013997:Time Factors
chemical_list: D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; D002154:Calpain; D000068759:Formoterol Fumarate